Legislature(2023 - 2024)BELTZ 105 (TSBldg)
03/20/2024 01:30 PM Senate LABOR & COMMERCE
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
Audio | Topic |
---|---|
Start | |
SB196 | |
SB121 | |
Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
+= | SB 196 | TELECONFERENCED | |
+= | SB 121 | TELECONFERENCED | |
SB 196-EMPLOYER DRUG AND ALCOHOL TESTING 1:36:51 PM CHAIR BJORKMAN announced the consideration of SENATE BILL NO. 196, "An Act relating to drug and alcohol testing by employers." 1:37:13 PM LAURA ACHEE, Staff, Senator Jesse Bjorkman, Alaska State Legislature, Juneau, Alaska, provided an overview of SB 196. She explained that SB 196 would allow employers to test employees for drug and alcohol use by taking oral fluid (saliva) samples. She stated that employers would be protected from lawsuits, provided they follow their written plan for drug and alcohol testing enacted in good faith. She noted that industry representatives would testify that SB 196 provides a convenient option, particularly in rural areas and places where restrooms are not readily available for urine testing. She recalled previous testimony that illustrated the need for alternative forms of testing and said that saliva testing would be effective in - and potentially eliminate - these situations. She added that saliva testing makes it easier to maintain a chain of custody, providing greater assurance that the sample is from the employee (which is done in a non-invasive manner). 1:38:55 PM CHAIR BJORKMAN opened public testimony on SB 196. 1:39:18 PM ED MARTIN, Co-owner, Kee Construction LLC, Kenai, Alaska, testified in support of SB 196. He stated that, as an employer, he supports drug testing and shared the circumstances under which he tests his employees. He emphasized that the drug testing is required by state law. He stated that he supports adding public officials and employees to the legislation. 1:41:31 PM CHAIR BJORKMAN closed public testimony on SB 196. 1:41:43 PM CHAIR BJORKMAN solicited a motion. 1:41:46 PM SENATOR BISHOP moved to report SB 196, work order 33-LS1144\A, from committee with individual recommendations and attached fiscal note(s). 1:42:05 PM CHAIR BJORKMAN found no objection and SB 196, was reported from the Senate Labor and Commerce Standing Committee.
Document Name | Date/Time | Subjects |
---|---|---|
SSSB121 Public Testimony-Letter_NABIP 03.20.24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Public Testimony-Letter_PHC 03.09.24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 DCCED-DOI Applicable Court Cases in Oklahoma and Arkansas 03.12.24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Mulready 10th Circuit Decision.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Public Testimony-Dianne Holmes 03.14.24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SB196 ver A.pdf |
SL&C 3/8/2024 1:30:00 PM SL&C 3/20/2024 1:30:00 PM |
SB 196 |
SB196 Sponsor Statement Version A.pdf |
SL&C 3/8/2024 1:30:00 PM SL&C 3/20/2024 1:30:00 PM |
SB 196 |
SB196 Sectional Analysis Version A.pdf |
SL&C 3/8/2024 1:30:00 PM SL&C 3/20/2024 1:30:00 PM |
SB 196 |
SB196 Fiscal Note-DOLWD-WH 03.02.24.pdf |
SL&C 3/8/2024 1:30:00 PM SL&C 3/20/2024 1:30:00 PM |
SB 196 |
SSSB121 Sectional Analysis ver H 02.12.24.pdf |
SL&C 2/28/2024 1:30:00 PM SL&C 3/11/2024 1:30:00 PM SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Sponsor Statement 02.11.24.pdf |
SL&C 2/28/2024 1:30:00 PM SL&C 3/11/2024 1:30:00 PM SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Fiscal Note-DCCED-CBPL-02.23.24.pdf |
SL&C 2/28/2024 1:30:00 PM SL&C 3/11/2024 1:30:00 PM SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Fiscal Note-DCCED-DOI-02.23.24.pdf |
SL&C 2/28/2024 1:30:00 PM SL&C 3/11/2024 1:30:00 PM SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 ver H.pdf |
SL&C 2/28/2024 1:30:00 PM SL&C 3/11/2024 1:30:00 PM SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Fiscal Note-DOA-DRB 02.24.24.pdf |
SL&C 2/28/2024 1:30:00 PM SL&C 3/11/2024 1:30:00 PM SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SB196 Public Testimony-Letter-RDC 02.29.24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 196 |
SSSB121 Public Testimony APRN Alliance 03.17.24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Public Testimony Nat. Psoriasis Foundation 03.15.24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Public Testimony Albertsons 03.19.24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Intro Slides Giessel 3-20-24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Public Testimony-CVS Brenda Snyder 03.20.24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |
SSSB121 Public Testimony ACPA 03.11.24.pdf |
SL&C 3/20/2024 1:30:00 PM |
SB 121 |